by The global clinical laboratory service market size is forecasted to reach from US$ 202.5 billion in 2021 to US$ 315.61 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The clinical laboratory service market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1387
The rapid growth of the research centers and increasing investments by the healthcare companies for the research and developmental activities results in reducing the complexity of current healthcare system.
Moreover, Clinical laboratory service system is registering it mark in the hospital, pharmacies, and health insurance sectors. The information based on these laboratory services are to make accurate decision while diagnose the patience. This is a major factor that boosts the growth of the global clinical laboratory service market.
The factors which augment the market are rising incidence of chronic diseases and rising demand for accurate disease diagnoses. Further, the rising adoption of innovative and automated technologies in the healthcare sector is boosting the adoption of the clinical laboratory service across the globe. The Clinical laboratory service is expected to change the way the hospitals and pharmacies operate by introducing innovative and data-centric methods and insights. Moreover,the growing penetration of cloud-based services in the healthcare sector is complementing the growth of the Clinical laboratory service market across the globe.
Report Scope of the Clinical Laboratory Service Market
| Report Highlights | Details |
| Market Size in 2030 | USD 315.61 Billion |
| Growth Rate | CAGR of 5.1% From 2021 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Test Type, Service Provider, Application, Region |
Competitive Intelligence
The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.
Some of the prominent players in the global clinical laboratory service market are listed as below:
- Qiagen
- Quest Diagnostics, Inc
- OPKO Health, Inc
- Abbott
- Charles River Laboratories; International, Inc
- Cinven
- Arup Laboratories
- Sonic Healthcare
- Laboratory Corporation of America Holdings (LabCorp)
- NeoGenomics Laboratories, Inc.
North America dominated the market in 2020. This is attributed to the increased adoption rate of the latest technologies in the countries like US and Canada. The presence of high number of health care companies along with the various contract manufacturing organizations and contract research organizations is benefiting the market in this region. The rising investment by the private players in the research activities for the development of various drugs for the treatment of chronic disease such as cancer, leukemia, lymphoma, muscular degeneration, and diabetes has necessitated the need for the efficient management of data and hence, the demand for the Clinical laboratory service increased rapidly in the region.
Asia Pacific is expected to be the most opportunistic market during the forecast period. The rising government expenditure to develop strong healthcare infrastructure and government policies to attract FDIs is expected to play a significant role in the growth of the Clinical laboratory service market in the region. The presence of huge population and rising number of hospital admissions will foster the demand for the Clinical laboratory service systems in the Asia Pacific region, and will lead to the growth of the market during the forecast period.
The rising prevalence of chronic diseases among the population will boost the demand for the health care services, pharmacies, and health insurances. Moreover, the increasing patient awareness, evolution to pathogens, advanced in area of healthcare and biotechnology in genomics & proteomics are the driving factors for the growth of the market.
The high costs associated with the acquisition of the latest clinical laboratory service may hamper the growth of the market. Further, lack of adequate infrastructure and capital in the underdeveloped and developing nations may hamper the market growth during the forecast period.
The introduction of latest technologies such as artificial intelligence and machine learning may provide growth prospects to the market players in the upcoming future, and drive the market growth.
Based on the type, the clinical chemistry segment is the leading and the fastest-growing segment. This can be attributed to the increasing investments in the research activities for the development of life-saving drugs and diagnosis procedures to treat various chronic diseases prevalent among the global population.
Based on the service provider, the hospital-based laboratories segment dominated the market. This can be attributed to the increased research activities and increased treatment of the cancer patients in the hospitals.According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe.
Based on the application, the bioanalytical and lab chemistry services segment was the leading segment in 2020. The rising prevalence of diseases coupled with the increased number of hospital admissions has significantly contributed towards the growth of this segment in the past few years. Moreover, rising investments for the development of better and improve healthcare infrastructure is boosting the growth of the hospitals especially in the developing regions.
Segments Covered in the Report
By Test Type
- Human & Tumor Genetics
- Clinical Chemistry
- Medical Microbiology & Cytology
- Other Esoteric Tests
By Service Provider
- Hospital-Based Laboratories
- Stand-Alone Laboratories
- Clinic-Based Laboratories
By Application
- Bioanalytical& Lab Chemistry Services
- Toxicology Testing Services
- Cell & Gene Therapy Related Services
- Preclinical & Clinical Trial Related Services
- Drug Discovery & Development Related Services
- Others
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Laboratory Service Market
5.1. COVID-19 Landscape: Clinical Laboratory Service Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Laboratory Service Market, By Test
8.1. Clinical Laboratory Service Market, by Test Type, 2021-2030
8.1.1. Human & Tumor Genetics
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Clinical Chemistry
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Medical Microbiology & Cytology
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Other Esoteric Tests
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Clinical Laboratory Service Market, By Application
9.1. Clinical Laboratory Service Market, by Application, 2021-2030
9.1.1. Bioanalytical& Lab Chemistry Services
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Toxicology Testing Services
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Cell & Gene Therapy Related Services
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Preclinical & Clinical Trial Related Services
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Drug Discovery & Development Related Services
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Clinical Laboratory Service Market, By Service Provider
10.1. Clinical Laboratory Service Market, by Service Provider, 2021-2030
10.1.1. Hospital-Based Laboratories
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Stand-Alone Laboratories
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Clinic-Based Laboratories
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Clinical Laboratory Service Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
Chapter 12. Company Profiles
12.1. Qiagen
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Quest Diagnostics, Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. OPKO Health, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Charles River Laboratories; International, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Cinven
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Arup Laboratories
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sonic Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Laboratory Corporation of America Holdings (LabCorp)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. NeoGenomics Laboratories, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global clinical laboratory service market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for clinical laboratory service are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1387
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
